nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0712	0.111	CbGbCtD
Nimodipine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0644	0.1	CbGbCtD
Nimodipine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0644	0.1	CbGbCtD
Nimodipine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0556	0.0867	CbGbCtD
Nimodipine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.054	0.0841	CbGbCtD
Nimodipine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0488	0.0761	CbGbCtD
Nimodipine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0488	0.0761	CbGbCtD
Nimodipine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0295	0.046	CbGbCtD
Nimodipine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0278	0.0433	CbGbCtD
Nimodipine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0278	0.0433	CbGbCtD
Nimodipine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0251	0.0391	CbGbCtD
Nimodipine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0251	0.0391	CbGbCtD
Nimodipine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0217	0.0338	CbGbCtD
Nimodipine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.021	0.0328	CbGbCtD
Nimodipine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.019	0.0297	CbGbCtD
Nimodipine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.019	0.0297	CbGbCtD
Nimodipine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0182	0.0284	CbGbCtD
Nimodipine—CACNA1F—retina—acquired immunodeficiency syndrome	0.0066	0.0671	CbGeAlD
Nimodipine—NR3C2—blood plasma—acquired immunodeficiency syndrome	0.003	0.0305	CbGeAlD
Nimodipine—CACNB4—spinal cord—acquired immunodeficiency syndrome	0.0028	0.0285	CbGeAlD
Nimodipine—CACNB4—vagina—acquired immunodeficiency syndrome	0.00269	0.0274	CbGeAlD
Nimodipine—CACNB4—lung—acquired immunodeficiency syndrome	0.00255	0.0259	CbGeAlD
Nimodipine—CACNB4—nervous system—acquired immunodeficiency syndrome	0.00236	0.024	CbGeAlD
Nimodipine—CACNB3—digestive system—acquired immunodeficiency syndrome	0.00233	0.0238	CbGeAlD
Nimodipine—CACNB4—central nervous system—acquired immunodeficiency syndrome	0.00227	0.0231	CbGeAlD
Nimodipine—CACNB1—spinal cord—acquired immunodeficiency syndrome	0.00223	0.0227	CbGeAlD
Nimodipine—CACNB2—retina—acquired immunodeficiency syndrome	0.00223	0.0227	CbGeAlD
Nimodipine—CACNB3—blood—acquired immunodeficiency syndrome	0.00222	0.0226	CbGeAlD
Nimodipine—CACNB3—vagina—acquired immunodeficiency syndrome	0.00206	0.021	CbGeAlD
Nimodipine—CACNB3—lung—acquired immunodeficiency syndrome	0.00195	0.0198	CbGeAlD
Nimodipine—CACNB1—nervous system—acquired immunodeficiency syndrome	0.00188	0.0192	CbGeAlD
Nimodipine—CACNB1—central nervous system—acquired immunodeficiency syndrome	0.00181	0.0184	CbGeAlD
Nimodipine—CACNB3—nervous system—acquired immunodeficiency syndrome	0.00181	0.0184	CbGeAlD
Nimodipine—CACNB4—brain—acquired immunodeficiency syndrome	0.0018	0.0183	CbGeAlD
Nimodipine—CACNB3—central nervous system—acquired immunodeficiency syndrome	0.00174	0.0177	CbGeAlD
Nimodipine—AHR—digestive system—acquired immunodeficiency syndrome	0.00173	0.0176	CbGeAlD
Nimodipine—AHR—blood—acquired immunodeficiency syndrome	0.00165	0.0168	CbGeAlD
Nimodipine—NR3C2—retina—acquired immunodeficiency syndrome	0.00164	0.0167	CbGeAlD
Nimodipine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.00162	0.0165	CbGeAlD
Nimodipine—AHR—bone marrow—acquired immunodeficiency syndrome	0.00159	0.0162	CbGeAlD
Nimodipine—AHR—spinal cord—acquired immunodeficiency syndrome	0.00159	0.0161	CbGeAlD
Nimodipine—CACNB2—digestive system—acquired immunodeficiency syndrome	0.00157	0.016	CbGeAlD
Nimodipine—AHR—vagina—acquired immunodeficiency syndrome	0.00153	0.0155	CbGeAlD
Nimodipine—CACNA1F—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.00151	0.0957	CbGpPWpGaD
Nimodipine—AHR—lung—acquired immunodeficiency syndrome	0.00144	0.0147	CbGeAlD
Nimodipine—CACNB1—brain—acquired immunodeficiency syndrome	0.00144	0.0146	CbGeAlD
Nimodipine—CACNB1—lymph node—acquired immunodeficiency syndrome	0.00139	0.0141	CbGeAlD
Nimodipine—CACNB2—vagina—acquired immunodeficiency syndrome	0.00139	0.0141	CbGeAlD
Nimodipine—CACNB3—brain—acquired immunodeficiency syndrome	0.00138	0.014	CbGeAlD
Nimodipine—CACNB3—lymph node—acquired immunodeficiency syndrome	0.00133	0.0136	CbGeAlD
Nimodipine—CACNB2—lung—acquired immunodeficiency syndrome	0.00131	0.0133	CbGeAlD
Nimodipine—CACNA1C—digestive system—acquired immunodeficiency syndrome	0.00127	0.0129	CbGeAlD
Nimodipine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00122	0.0124	CbGeAlD
Nimodipine—CACNB2—nervous system—acquired immunodeficiency syndrome	0.00121	0.0123	CbGeAlD
Nimodipine—AHR—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00118	0.0749	CbGpPWpGaD
Nimodipine—CACNB2—central nervous system—acquired immunodeficiency syndrome	0.00117	0.0119	CbGeAlD
Nimodipine—NR3C2—digestive system—acquired immunodeficiency syndrome	0.00115	0.0117	CbGeAlD
Nimodipine—CACNA1D—lung—acquired immunodeficiency syndrome	0.00115	0.0116	CbGeAlD
Nimodipine—CACNA1C—vagina—acquired immunodeficiency syndrome	0.00112	0.0114	CbGeAlD
Nimodipine—NR3C2—blood—acquired immunodeficiency syndrome	0.0011	0.0112	CbGeAlD
Nimodipine—CACNB4—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.00106	0.0674	CbGpPWpGaD
Nimodipine—CACNA1D—nervous system—acquired immunodeficiency syndrome	0.00106	0.0108	CbGeAlD
Nimodipine—NR3C2—spinal cord—acquired immunodeficiency syndrome	0.00106	0.0108	CbGeAlD
Nimodipine—CACNA1C—lung—acquired immunodeficiency syndrome	0.00106	0.0108	CbGeAlD
Nimodipine—AHR—brain—acquired immunodeficiency syndrome	0.00102	0.0104	CbGeAlD
Nimodipine—CACNA1D—central nervous system—acquired immunodeficiency syndrome	0.00102	0.0104	CbGeAlD
Nimodipine—NR3C2—vagina—acquired immunodeficiency syndrome	0.00102	0.0103	CbGeAlD
Nimodipine—AHR—lymph node—acquired immunodeficiency syndrome	0.000988	0.0101	CbGeAlD
Nimodipine—CACNA1C—nervous system—acquired immunodeficiency syndrome	0.000979	0.00996	CbGeAlD
Nimodipine—NR3C2—lung—acquired immunodeficiency syndrome	0.000962	0.00979	CbGeAlD
Nimodipine—CACNA1C—central nervous system—acquired immunodeficiency syndrome	0.000942	0.00959	CbGeAlD
Nimodipine—CACNB2—brain—acquired immunodeficiency syndrome	0.000927	0.00943	CbGeAlD
Nimodipine—CACNB2—lymph node—acquired immunodeficiency syndrome	0.000896	0.00912	CbGeAlD
Nimodipine—NR3C2—nervous system—acquired immunodeficiency syndrome	0.000891	0.00906	CbGeAlD
Nimodipine—NR3C2—central nervous system—acquired immunodeficiency syndrome	0.000858	0.00873	CbGeAlD
Nimodipine—CACNB3—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.00085	0.0539	CbGpPWpGaD
Nimodipine—CACNB1—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.000827	0.0524	CbGpPWpGaD
Nimodipine—CACNA1D—brain—acquired immunodeficiency syndrome	0.00081	0.00825	CbGeAlD
Nimodipine—AHR—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.000802	0.0509	CbGpPWpGaD
Nimodipine—CACNA1D—lymph node—acquired immunodeficiency syndrome	0.000783	0.00797	CbGeAlD
Nimodipine—CACNA1C—brain—acquired immunodeficiency syndrome	0.000748	0.00761	CbGeAlD
Nimodipine—CACNA1C—lymph node—acquired immunodeficiency syndrome	0.000723	0.00735	CbGeAlD
Nimodipine—Sweating increased—Lamivudine—acquired immunodeficiency syndrome	0.000699	0.00286	CcSEcCtD
Nimodipine—Depression—Ritonavir—acquired immunodeficiency syndrome	0.000695	0.00284	CcSEcCtD
Nimodipine—Flushing—Indinavir—acquired immunodeficiency syndrome	0.000694	0.00284	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.00069	0.00283	CcSEcCtD
Nimodipine—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.000689	0.00282	CcSEcCtD
Nimodipine—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.000688	0.00282	CcSEcCtD
Nimodipine—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.000686	0.00281	CcSEcCtD
Nimodipine—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.000681	0.00279	CcSEcCtD
Nimodipine—NR3C2—brain—acquired immunodeficiency syndrome	0.000681	0.00693	CbGeAlD
Nimodipine—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.000679	0.00278	CcSEcCtD
Nimodipine—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.000676	0.00277	CcSEcCtD
Nimodipine—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.000676	0.00277	CcSEcCtD
Nimodipine—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.000676	0.00277	CcSEcCtD
Nimodipine—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.000673	0.00276	CcSEcCtD
Nimodipine—Depression—Saquinavir—acquired immunodeficiency syndrome	0.000669	0.00274	CcSEcCtD
Nimodipine—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000668	0.00273	CcSEcCtD
Nimodipine—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000667	0.00273	CcSEcCtD
Nimodipine—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00066	0.0027	CcSEcCtD
Nimodipine—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.000659	0.0027	CcSEcCtD
Nimodipine—NR3C2—lymph node—acquired immunodeficiency syndrome	0.000658	0.00669	CbGeAlD
Nimodipine—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.000656	0.00269	CcSEcCtD
Nimodipine—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.000656	0.00269	CcSEcCtD
Nimodipine—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.000654	0.00268	CcSEcCtD
Nimodipine—Oedema—Abacavir—acquired immunodeficiency syndrome	0.000648	0.00265	CcSEcCtD
Nimodipine—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000647	0.00265	CcSEcCtD
Nimodipine—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000646	0.00264	CcSEcCtD
Nimodipine—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000645	0.00264	CcSEcCtD
Nimodipine—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000644	0.00264	CcSEcCtD
Nimodipine—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000641	0.00263	CcSEcCtD
Nimodipine—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000639	0.00261	CcSEcCtD
Nimodipine—Depression—Lamivudine—acquired immunodeficiency syndrome	0.000638	0.00261	CcSEcCtD
Nimodipine—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.000638	0.00261	CcSEcCtD
Nimodipine—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.000636	0.0026	CcSEcCtD
Nimodipine—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000635	0.0026	CcSEcCtD
Nimodipine—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000634	0.0026	CcSEcCtD
Nimodipine—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.000634	0.0026	CcSEcCtD
Nimodipine—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.000626	0.00256	CcSEcCtD
Nimodipine—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.000626	0.00256	CcSEcCtD
Nimodipine—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.000624	0.00255	CcSEcCtD
Nimodipine—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000623	0.00634	CbGeAlD
Nimodipine—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000621	0.00254	CcSEcCtD
Nimodipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.000606	0.0384	CbGpPWpGaD
Nimodipine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000605	0.00248	CcSEcCtD
Nimodipine—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.000605	0.00248	CcSEcCtD
Nimodipine—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.000602	0.00246	CcSEcCtD
Nimodipine—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000602	0.00246	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000601	0.00246	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000599	0.00245	CcSEcCtD
Nimodipine—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000596	0.00244	CcSEcCtD
Nimodipine—CYP3A5—blood—acquired immunodeficiency syndrome	0.000593	0.00604	CbGeAlD
Nimodipine—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00059	0.00242	CcSEcCtD
Nimodipine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000588	0.00241	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000588	0.00241	CcSEcCtD
Nimodipine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000588	0.00241	CcSEcCtD
Nimodipine—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.000581	0.00238	CcSEcCtD
Nimodipine—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000581	0.00238	CcSEcCtD
Nimodipine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000578	0.00236	CcSEcCtD
Nimodipine—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000576	0.00236	CcSEcCtD
Nimodipine—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000574	0.00235	CcSEcCtD
Nimodipine—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000572	0.00234	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00057	0.00233	CcSEcCtD
Nimodipine—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000569	0.00233	CcSEcCtD
Nimodipine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000569	0.00233	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000568	0.00232	CcSEcCtD
Nimodipine—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000568	0.00232	CcSEcCtD
Nimodipine—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000566	0.00232	CcSEcCtD
Nimodipine—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000565	0.00231	CcSEcCtD
Nimodipine—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000561	0.00229	CcSEcCtD
Nimodipine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00056	0.00229	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000559	0.00229	CcSEcCtD
Nimodipine—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000559	0.00229	CcSEcCtD
Nimodipine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000558	0.00228	CcSEcCtD
Nimodipine—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000555	0.00227	CcSEcCtD
Nimodipine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000553	0.00226	CcSEcCtD
Nimodipine—CYP3A5—vagina—acquired immunodeficiency syndrome	0.00055	0.00559	CbGeAlD
Nimodipine—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000546	0.00224	CcSEcCtD
Nimodipine—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000544	0.00223	CcSEcCtD
Nimodipine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000544	0.00223	CcSEcCtD
Nimodipine—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000544	0.00223	CcSEcCtD
Nimodipine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000536	0.00219	CcSEcCtD
Nimodipine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000532	0.00218	CcSEcCtD
Nimodipine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000531	0.00217	CcSEcCtD
Nimodipine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000528	0.00216	CcSEcCtD
Nimodipine—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000524	0.00214	CcSEcCtD
Nimodipine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000524	0.00214	CcSEcCtD
Nimodipine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000524	0.00214	CcSEcCtD
Nimodipine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000523	0.00214	CcSEcCtD
Nimodipine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000521	0.00213	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000521	0.00213	CcSEcCtD
Nimodipine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000521	0.00213	CcSEcCtD
Nimodipine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00052	0.00213	CcSEcCtD
Nimodipine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00052	0.00213	CcSEcCtD
Nimodipine—CYP3A5—lung—acquired immunodeficiency syndrome	0.00052	0.00529	CbGeAlD
Nimodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.000519	0.0329	CbGpPWpGaD
Nimodipine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000519	0.00212	CcSEcCtD
Nimodipine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000518	0.00212	CcSEcCtD
Nimodipine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000514	0.0021	CcSEcCtD
Nimodipine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00051	0.00209	CcSEcCtD
Nimodipine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000508	0.00208	CcSEcCtD
Nimodipine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000504	0.00206	CcSEcCtD
Nimodipine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000503	0.00206	CcSEcCtD
Nimodipine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000502	0.00205	CcSEcCtD
Nimodipine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000501	0.00205	CcSEcCtD
Nimodipine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000494	0.00202	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000493	0.00202	CcSEcCtD
Nimodipine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000493	0.00202	CcSEcCtD
Nimodipine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000492	0.00201	CcSEcCtD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.000492	0.0312	CbGpPWpGaD
Nimodipine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00049	0.00201	CcSEcCtD
Nimodipine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000486	0.00199	CcSEcCtD
Nimodipine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000486	0.00199	CcSEcCtD
Nimodipine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000485	0.00198	CcSEcCtD
Nimodipine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000484	0.00198	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000484	0.00198	CcSEcCtD
Nimodipine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000482	0.00197	CcSEcCtD
Nimodipine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000482	0.00197	CcSEcCtD
Nimodipine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000481	0.00197	CcSEcCtD
Nimodipine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000481	0.00197	CcSEcCtD
Nimodipine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000481	0.00197	CcSEcCtD
Nimodipine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000478	0.00196	CcSEcCtD
Nimodipine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000477	0.00195	CcSEcCtD
Nimodipine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000477	0.00195	CcSEcCtD
Nimodipine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000475	0.00194	CcSEcCtD
Nimodipine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000474	0.00194	CcSEcCtD
Nimodipine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000471	0.00193	CcSEcCtD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—ACTG1—acquired immunodeficiency syndrome	0.00047	0.0298	CbGpPWpGaD
Nimodipine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00047	0.00192	CcSEcCtD
Nimodipine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000469	0.00192	CcSEcCtD
Nimodipine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000467	0.00475	CbGeAlD
Nimodipine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000467	0.00191	CcSEcCtD
Nimodipine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000466	0.00191	CcSEcCtD
Nimodipine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000465	0.0019	CcSEcCtD
Nimodipine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000465	0.0019	CcSEcCtD
Nimodipine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000464	0.0019	CcSEcCtD
Nimodipine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000462	0.00189	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000459	0.00188	CcSEcCtD
Nimodipine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000458	0.00188	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000458	0.00187	CcSEcCtD
Nimodipine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000452	0.00185	CcSEcCtD
Nimodipine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000451	0.00185	CcSEcCtD
Nimodipine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00045	0.00184	CcSEcCtD
Nimodipine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00045	0.00184	CcSEcCtD
Nimodipine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000449	0.00184	CcSEcCtD
Nimodipine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000448	0.00183	CcSEcCtD
Nimodipine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000446	0.00183	CcSEcCtD
Nimodipine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000445	0.00453	CbGeAlD
Nimodipine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000444	0.00182	CcSEcCtD
Nimodipine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000443	0.00181	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000438	0.00179	CcSEcCtD
Nimodipine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000436	0.00179	CcSEcCtD
Nimodipine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000436	0.00178	CcSEcCtD
Nimodipine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000435	0.00178	CcSEcCtD
Nimodipine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000435	0.00178	CcSEcCtD
Nimodipine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000434	0.00178	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000434	0.00177	CcSEcCtD
Nimodipine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000433	0.00177	CcSEcCtD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.000432	0.0274	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00043	0.00176	CcSEcCtD
Nimodipine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000429	0.00176	CcSEcCtD
Nimodipine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000429	0.00176	CcSEcCtD
Nimodipine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000428	0.00175	CcSEcCtD
Nimodipine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000428	0.00175	CcSEcCtD
Nimodipine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000428	0.00175	CcSEcCtD
Nimodipine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000427	0.00175	CcSEcCtD
Nimodipine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000426	0.00174	CcSEcCtD
Nimodipine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000419	0.00172	CcSEcCtD
Nimodipine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000419	0.00172	CcSEcCtD
Nimodipine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000419	0.00171	CcSEcCtD
Nimodipine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000418	0.00171	CcSEcCtD
Nimodipine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000416	0.0017	CcSEcCtD
Nimodipine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000416	0.0017	CcSEcCtD
Nimodipine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000415	0.0017	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000415	0.0017	CcSEcCtD
Nimodipine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000415	0.0017	CcSEcCtD
Nimodipine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000414	0.0017	CcSEcCtD
Nimodipine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000414	0.00169	CcSEcCtD
Nimodipine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000413	0.00169	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000413	0.0262	CbGpPWpGaD
Nimodipine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000412	0.00169	CcSEcCtD
Nimodipine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000412	0.00169	CcSEcCtD
Nimodipine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000408	0.00167	CcSEcCtD
Nimodipine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000408	0.00167	CcSEcCtD
Nimodipine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000408	0.00167	CcSEcCtD
Nimodipine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000406	0.00166	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000405	0.00166	CcSEcCtD
Nimodipine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000405	0.00166	CcSEcCtD
Nimodipine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000404	0.00166	CcSEcCtD
Nimodipine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.0004	0.00164	CcSEcCtD
Nimodipine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.0004	0.00164	CcSEcCtD
Nimodipine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.0004	0.00164	CcSEcCtD
Nimodipine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000396	0.00162	CcSEcCtD
Nimodipine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000394	0.00161	CcSEcCtD
Nimodipine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000392	0.0016	CcSEcCtD
Nimodipine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000392	0.0016	CcSEcCtD
Nimodipine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000391	0.0016	CcSEcCtD
Nimodipine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000391	0.0016	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00039	0.0016	CcSEcCtD
Nimodipine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000385	0.00158	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000384	0.00157	CcSEcCtD
Nimodipine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000381	0.00156	CcSEcCtD
Nimodipine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000381	0.00156	CcSEcCtD
Nimodipine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000378	0.00155	CcSEcCtD
Nimodipine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000376	0.00154	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000372	0.00152	CcSEcCtD
Nimodipine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00037	0.00151	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000369	0.00151	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000367	0.0233	CbGpPWpGaD
Nimodipine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000364	0.00149	CcSEcCtD
Nimodipine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000364	0.00149	CcSEcCtD
Nimodipine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000363	0.00149	CcSEcCtD
Nimodipine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000361	0.00368	CbGeAlD
Nimodipine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00036	0.00148	CcSEcCtD
Nimodipine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00036	0.00147	CcSEcCtD
Nimodipine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000358	0.00147	CcSEcCtD
Nimodipine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.00145	CcSEcCtD
Nimodipine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000354	0.00145	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000352	0.00144	CcSEcCtD
Nimodipine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000352	0.00144	CcSEcCtD
Nimodipine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000348	0.00354	CbGeAlD
Nimodipine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000344	0.00141	CcSEcCtD
Nimodipine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.00139	CcSEcCtD
Nimodipine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00034	0.00139	CcSEcCtD
Nimodipine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000338	0.00138	CcSEcCtD
Nimodipine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000335	0.00137	CcSEcCtD
Nimodipine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000335	0.00137	CcSEcCtD
Nimodipine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000333	0.00136	CcSEcCtD
Nimodipine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000332	0.00136	CcSEcCtD
Nimodipine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000329	0.00135	CcSEcCtD
Nimodipine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000327	0.00134	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000326	0.0207	CbGpPWpGaD
Nimodipine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000319	0.00131	CcSEcCtD
Nimodipine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000318	0.0013	CcSEcCtD
Nimodipine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.0013	CcSEcCtD
Nimodipine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000316	0.0013	CcSEcCtD
Nimodipine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000316	0.00129	CcSEcCtD
Nimodipine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000315	0.00129	CcSEcCtD
Nimodipine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000315	0.00129	CcSEcCtD
Nimodipine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.00129	CcSEcCtD
Nimodipine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.00125	CcSEcCtD
Nimodipine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.00124	CcSEcCtD
Nimodipine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000303	0.00124	CcSEcCtD
Nimodipine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000303	0.00124	CcSEcCtD
Nimodipine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.00124	CcSEcCtD
Nimodipine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.00123	CcSEcCtD
Nimodipine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000301	0.00123	CcSEcCtD
Nimodipine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000298	0.00122	CcSEcCtD
Nimodipine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.0012	CcSEcCtD
Nimodipine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.0012	CcSEcCtD
Nimodipine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.00118	CcSEcCtD
Nimodipine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000285	0.00117	CcSEcCtD
Nimodipine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.00116	CcSEcCtD
Nimodipine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.00116	CcSEcCtD
Nimodipine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00115	CcSEcCtD
Nimodipine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00115	CcSEcCtD
Nimodipine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.00114	CcSEcCtD
Nimodipine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.00114	CcSEcCtD
Nimodipine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.00111	CcSEcCtD
Nimodipine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.0011	CcSEcCtD
Nimodipine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.0011	CcSEcCtD
Nimodipine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.0011	CcSEcCtD
Nimodipine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.0011	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000267	0.017	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000267	0.017	CbGpPWpGaD
Nimodipine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.00108	CcSEcCtD
Nimodipine—CACNB3—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000261	0.0165	CbGpPWpGaD
Nimodipine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.00106	CcSEcCtD
Nimodipine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00105	CcSEcCtD
Nimodipine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00105	CcSEcCtD
Nimodipine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.00105	CcSEcCtD
Nimodipine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00104	CcSEcCtD
Nimodipine—CACNB1—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000254	0.0161	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.00025	0.0159	CbGpPWpGaD
Nimodipine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.000992	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000233	0.0148	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000205	0.013	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000186	0.0118	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000186	0.0118	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000181	0.0115	CbGpPWpGaD
Nimodipine—CACNB4—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	0.00016	0.0102	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000159	0.0101	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000151	0.00957	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000133	0.00841	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000133	0.00841	CbGpPWpGaD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	0.000128	0.00813	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000126	0.00797	CbGpPWpGaD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	0.000125	0.00791	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—TNF—acquired immunodeficiency syndrome	0.000116	0.00739	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000114	0.00721	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000108	0.00683	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000107	0.00677	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.0001	0.00637	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—CCNT1—acquired immunodeficiency syndrome	9.86e-05	0.00625	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	9.46e-05	0.006	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—IL6—acquired immunodeficiency syndrome	9.4e-05	0.00596	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	9.14e-05	0.0058	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	8.15e-05	0.00517	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	7.83e-05	0.00497	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TAT—acquired immunodeficiency syndrome	7.67e-05	0.00487	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	7.42e-05	0.00471	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TAT—acquired immunodeficiency syndrome	7.27e-05	0.00461	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	7.17e-05	0.00454	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	6.63e-05	0.00421	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	6.63e-05	0.00421	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AGPS—acquired immunodeficiency syndrome	6.52e-05	0.00414	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—acquired immunodeficiency syndrome	6.52e-05	0.00413	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TAT—acquired immunodeficiency syndrome	6.38e-05	0.00405	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AGPS—acquired immunodeficiency syndrome	6.18e-05	0.00392	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AGPS—acquired immunodeficiency syndrome	5.43e-05	0.00344	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—IL6—acquired immunodeficiency syndrome	4.6e-05	0.00292	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TNF—acquired immunodeficiency syndrome	4.07e-05	0.00258	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—IL6—acquired immunodeficiency syndrome	3.68e-05	0.00233	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—IL6—acquired immunodeficiency syndrome	3.58e-05	0.00227	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—IL6—acquired immunodeficiency syndrome	3.28e-05	0.00208	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—acquired immunodeficiency syndrome	3.25e-05	0.00206	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—acquired immunodeficiency syndrome	3.16e-05	0.00201	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	2.83e-05	0.00179	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.62e-05	0.00166	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6—acquired immunodeficiency syndrome	2.62e-05	0.00166	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.55e-05	0.00162	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	2.4e-05	0.00152	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.32e-05	0.00147	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6—acquired immunodeficiency syndrome	2.25e-05	0.00143	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ALB—acquired immunodeficiency syndrome	2.19e-05	0.00139	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—acquired immunodeficiency syndrome	2.13e-05	0.00135	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.99e-05	0.00126	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.88e-05	0.00119	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.87e-05	0.00119	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—acquired immunodeficiency syndrome	1.87e-05	0.00119	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.65e-05	0.00105	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.6e-05	0.00102	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.52e-05	0.000963	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALB—acquired immunodeficiency syndrome	1.34e-05	0.000849	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.33e-05	0.000846	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.31e-05	0.000833	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALB—acquired immunodeficiency syndrome	1.27e-05	0.000804	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.12e-05	0.000709	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALB—acquired immunodeficiency syndrome	1.11e-05	0.000706	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	4.93e-06	0.000313	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.29e-06	0.000145	CbGpPWpGaD
